End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2.95 RON | +4.24% |
|
-1.99% | +111.47% |
06-06 | Antibiotice S.A. announced that it expects to receive $108.96 million in funding | CI |
05-15 | Antibiotice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Business Summary
Number of employees: 1,352
Sales per Business
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical Products
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Sales per region
RON in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Romania
100.0
%
| 366 | 100.0 % | 483 | 100.0 % | +31.80% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 86-12-31 |
Director of Finance/CFO | 56 | 90-12-31 | |
Cornelia Moraru
CTO | Chief Tech/Sci/R&D Officer | 58 | 03-01-04 |
Investor Relations Contact | - | - | |
Mihaela Murariu
HRO | Human Resources Officer | 46 | 22-09-06 |
Liviu Vatavu
LAW | General Counsel | 51 | 19-01-08 |
Ovidiu Bataga
SAM | Sales & Marketing | 46 | 01-01-31 |
Vasile Chebac
PRN | Corporate Officer/Principal | 69 | 71-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ioan Nani
CEO | Chief Executive Officer | 64 | 86-12-31 |
Mihai Trifu
BRD | Director/Board Member | 41 | 21-08-25 |
Director/Board Member | 48 | 21-08-25 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 671,338,040 | 117,937,079 ( 17.57 %) | 0 | 17.57 % |
Company contact information
![address Antibiotice S.A.(ATB)](https://cdn.zonebourse.com/static/address/6496920.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+111.47% | 426M | |
+55.32% | 815B | |
+43.42% | 641B | |
-6.75% | 352B | |
+13.56% | 314B | |
+10.68% | 303B | |
+16.10% | 242B | |
+2.09% | 224B | |
+13.06% | 218B | |
+8.48% | 168B |
- Stock Market
- Equities
- ATB Stock
- Company Antibiotice S.A.